We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$24.3B
Cap. Flow
-$1.52B
Cap. Flow %
-0.29%
Top 10 Hldgs %
29.53%
Holding
15,731
New
1,614
Increased
6,434
Reduced
5,866
Closed
1,611

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$555M
2
C icon
Citigroup
C
+$407M
3
MDT icon
Medtronic
MDT
+$401M
4
CMG icon
Chipotle Mexican Grill
CMG
+$392M
5
GILD icon
Gilead Sciences
GILD
+$362M

Sector Composition

Rank Sector Weight
1 Technology 3.02%
2 Healthcare 2.92%
3 Consumer Discretionary 2.17%
4 Financials 2.1%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMGA
14026
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$60 ﹤0.01%
49
-1,033,086
-100% -$1.64M
RGLS
14027
DELISTED
Regulus Therapeutics
RGLS
$50 ﹤0.01%
+32
New +$53
SBEV icon
14028
PUT
Splash Beverage Group
SBEV
$2.54M
$50 ﹤0.01%
1
-4
-80% -$201
VWO icon
14029
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$48 ﹤0.01%
1
-1,122,962
-100% -$50M
BROGW
14030
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
$48 ﹤0.01%
11,952
+695
+6% +$3
ATNM icon
14031
Actinium Pharmaceuticals
ATNM
$31.4M
$43 ﹤0.01%
23
-65,454
-100% -$259K
KXIN icon
14032
PUT
Kaixin Holdings
KXIN
$8.48M
0
OGI
14033
Organigram Holdings
OGI
$172M
$38 ﹤0.01%
21
-28,954
-100% -$50.4K
PACB icon
14034
Pacific Biosciences
PACB
$354M
$37 ﹤0.01%
22
-904,179
-100% -$1.49M
ACHV icon
14035
Achieve Life Sciences
ACHV
$756M
$28 ﹤0.01%
+6
New +$27
ENSV
14036
PUT
DELISTED
Enservco Corp.
ENSV
$26 ﹤0.01%
+200
New +$34
SANW
14037
PUT
DELISTED
S&W Seed Co
SANW
$19 ﹤0.01%
5
UUUU icon
14038
Energy Fuels
UUUU
$3.78B
$16 ﹤0.01%
3
-224,721
-100% -$1.17M
GTE icon
14039
Gran Tierra Energy
GTE
$337M
$13 ﹤0.01%
2
-1,049
-100% -$8.41K
VANI icon
14040
Vivani Medical
VANI
$117M
$9 ﹤0.01%
+8
New +$10
KNDI
14041
Kandi Technologies Group
KNDI
$63.5M
$6 ﹤0.01%
3
-97
-97% -$176
AACG
14042
ATA Creativity
AACG
$43.6M
-50,580
Closed -$39.5K
AAXJ icon
14043
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
-4,200
Closed -$302K
AAXJ icon
14044
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
-500
Closed -$36K
ABCS icon
14045
Alpha Blue Capital US Small-Mid Cap Dynamic ETF
ABCS
$12.8M
-7,701
Closed -$200K
ABEV icon
14046
Ambev
ABEV
$43B
-762,194
Closed -$1.71M
ABSI icon
14047
Absci
ABSI
$1.54B
-846,826
Closed -$3.37M
ABVC icon
14048
ABVC BioPharma
ABVC
$23.7M
-25,212
Closed -$19.5K
ACON icon
14049
Aclarion
ACON
$6.01M
-3
Closed -$8.24K
ACTV
14050
DELISTED
LeaderShares Activist Leaders ETF
ACTV
-9,079
Closed -$291K

Similar funds

Citadel Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
  • Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
  • Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
  • Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
  • Citadel Advisors opened 1,614 new positions and closed 1,611 in Q3 2024.
  • Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.